Asio Capital LLC grew its stake in shares of CVS Health Co. (NYSE:CVS – Get Rating) by 5.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,960 shares of the pharmacy operator’s stock after purchasing an additional 1,353 shares during the period. Asio Capital LLC’s holdings in CVS Health were worth $2,606,000 as of its most recent SEC filing.
→ BREAKING: Tiny biotech successfully treats blindness (From Behind the Markets)
Other large investors have also recently modified their holdings of the company. SRS Capital Advisors Inc. boosted its stake in shares of CVS Health by 105.8% during the 3rd quarter. SRS Capital Advisors Inc. now owns 284 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 146 shares in the last quarter. Godsey & Gibb Inc. bought a new stake in shares of CVS Health during the 4th quarter valued at about $28,000. Karp Capital Management Corp bought a new stake in shares of CVS Health during the 3rd quarter valued at about $30,000. EWG Elevate Inc. purchased a new position in CVS Health during the 4th quarter valued at about $32,000. Finally, Coston McIsaac & Partners purchased a new position in CVS Health during the 2nd quarter valued at about $34,000. Institutional investors own 77.29% of the company’s stock.
Wall Street Analysts Forecast Growth
CVS has been the subject of a number of recent research reports. Morgan Stanley lifted their price target on shares of CVS Health from $119.00 to $120.00 and gave the company an “overweight” rating in a research report on Friday, January 13th. Bank of America lowered their price target on shares of CVS Health from $111.00 to $104.00 and set a “buy” rating for the company in a research report on Friday, March 31st. Royal Bank of Canada reissued an “outperform” rating and set a $115.00 price target on shares of CVS Health in a research report on Thursday, February 9th. StockNews.com started coverage on shares of CVS Health in a research report on Thursday, March 16th. They set a “buy” rating for the company. Finally, Wells Fargo & Company decreased their target price on shares of CVS Health from $106.00 to $101.00 and set an “equal weight” rating for the company in a report on Tuesday, January 3rd. Two investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $118.24.
CVS Health Stock Performance
Shares of CVS traded down $0.21 during mid-day trading on Friday, hitting $77.54. 8,778,251 shares of the company traded hands, compared to its average volume of 8,028,157. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.67 and a current ratio of 0.94. The stock has a 50-day moving average price of $81.57 and a two-hundred day moving average price of $90.54. CVS Health Co. has a 1 year low of $72.11 and a 1 year high of $107.73. The stock has a market cap of $99.57 billion, a price-to-earnings ratio of 24.85, a P/E/G ratio of 1.18 and a beta of 0.61.
CVS Health (NYSE:CVS – Get Rating) last released its quarterly earnings results on Wednesday, February 8th. The pharmacy operator reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.07. The business had revenue of $83.85 billion for the quarter, compared to the consensus estimate of $76.37 billion. CVS Health had a net margin of 1.29% and a return on equity of 15.75%. The company’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period last year, the firm earned $1.98 earnings per share. Equities analysts anticipate that CVS Health Co. will post 8.83 earnings per share for the current year.
CVS Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, May 1st. Investors of record on Friday, April 21st will be paid a dividend of $0.605 per share. The ex-dividend date of this dividend is Thursday, April 20th. This represents a $2.42 annualized dividend and a yield of 3.12%. CVS Health’s payout ratio is 77.56%.
CVS Health Profile
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and CVS Health wasn’t on the list.
While CVS Health currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Elon Musk’s Next Move
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Source: marketbeat.com
